Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation by Zemke, Martina et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2015
Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene
derepression and Wnt-dependent regulation
Zemke, Martina; Draganova, Kalina; Klug, Annika; Schöler, Anne; Zurkirchen, Luis; Gay, Max
Hans-Peter; Cheng, Phil; Koseki, Haruhiko; Valenta, Tomas; Schübeler, Dirk; Basler, Konrad; Sommer,
Lukas
Abstract: BACKGROUND: Precise spatiotemporal control of gene expression is essential for the estab-
lishment of correct cell numbers and identities during brain development. This process involves epige-
netic control mechanisms, such as those mediated by the polycomb group protein Ezh2, which catalyzes
trimethylation of histone H3K27 (H3K27me3) and thereby represses gene expression. RESULTS: Herein,
we show that Ezh2 plays a crucial role in the development and maintenance of the midbrain. Conditional
deletion of Ezh2 in the developing midbrain resulted in decreased neural progenitor proliferation, which
is associated with derepression of cell cycle inhibitors and negative regulation of Wnt/￿-catenin signaling.
Of note, Ezh2 ablation also promoted ectopic expression of a forebrain transcriptional program involving
derepression of the forebrain determinants Foxg1 and Pax6. This was accompanied by reduced expression
of midbrain markers, including Pax3 and Pax7, as a consequence of decreased Wnt/￿-catenin signaling.
CONCLUSION: Ezh2 is required for appropriate brain growth and maintenance of regional identity by
H3K27me3-mediated gene repression and control of canonical Wnt signaling.
DOI: 10.1186/s12915-015-0210-9
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-115847
Published Version
 
 
Originally published at:
Zemke, Martina; Draganova, Kalina; Klug, Annika; Schöler, Anne; Zurkirchen, Luis; Gay, Max Hans-
Peter; Cheng, Phil; Koseki, Haruhiko; Valenta, Tomas; Schübeler, Dirk; Basler, Konrad; Sommer, Lukas
(2015). Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and
Wnt-dependent regulation. BMC Biology, 13:103. DOI: 10.1186/s12915-015-0210-9
Loss of Ezh2 promotes a midbrain-to-forebrain identity
switch by direct gene derepression and Wnt-
dependent regulation
Zemke et al.
Zemke et al. BMC Biology  (2015) 13:103 
DOI 10.1186/s12915-015-0210-9
RESEARCH ARTICLE Open Access
Loss of Ezh2 promotes a midbrain-to-forebrain
identity switch by direct gene derepression and
Wnt-dependent regulation
Martina Zemke1, Kalina Draganova1, Annika Klug1, Anne Schöler2, Luis Zurkirchen1, Max Hans-Peter Gay1,
Phil Cheng3, Haruhiko Koseki4, Tomas Valenta5, Dirk Schübeler2, Konrad Basler5 and Lukas Sommer1*
Abstract
Background: Precise spatiotemporal control of gene expression is essential for the establishment of correct cell
numbers and identities during brain development. This process involves epigenetic control mechanisms, such as
those mediated by the polycomb group protein Ezh2, which catalyzes trimethylation of histone H3K27 (H3K27me3)
and thereby represses gene expression.
Results: Herein, we show that Ezh2 plays a crucial role in the development and maintenance of the midbrain.
Conditional deletion of Ezh2 in the developing midbrain resulted in decreased neural progenitor proliferation,
which is associated with derepression of cell cycle inhibitors and negative regulation of Wnt/β-catenin signaling. Of
note, Ezh2 ablation also promoted ectopic expression of a forebrain transcriptional program involving derepression
of the forebrain determinants Foxg1 and Pax6. This was accompanied by reduced expression of midbrain markers,
including Pax3 and Pax7, as a consequence of decreased Wnt/β-catenin signaling.
Conclusion: Ezh2 is required for appropriate brain growth and maintenance of regional identity by H3K27me3-
mediated gene repression and control of canonical Wnt signaling.
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Background
During organogenesis, cell proliferation, differentiation,
and morphogenesis have to be tightly coordinated. This
process involves extensive changes in gene expression,
which entails epigenetic mechanisms such as DNA me-
thylation, nucleosome remodeling, and post-translational
modifications of the histones [1]. Epigenetic modifications
mark the genome as regions that are either accessible or
closed for the transcription machinery. Since these modifi-
cations can be inherited through cell divisions, epigenetic
control is thought to maintain identity and behavior of a
given cell type. Accordingly, fate switches associated, for in-
stance, with the transition from a proliferative multipotent
progenitor cell to a non-dividing terminally differentiated
cell type, are accompanied and potentially controlled by
changes in epigenetic information.
Key players in this process are polycomb group (PcG)
proteins that form two complexes, polycomb repressive
complex (PRC) 1 and PRC2, which repress gene activity
by catalyzing trimethylation of lysine 27 on histone H3
(H3K27me3) [2, 3]. The catalytic subunit of PRC2 is the
methyltransferase enhancer of zeste homolog 2 (Ezh2)
or its homolog Ezh1 [4]. Ezh2 is essential for vertebrate
development since mice lacking Ezh2 die around gastru-
lation [5]. A role of PcG proteins in the developing ner-
vous system was suggested by experiments in embryonic
stem cells undergoing neural differentiation, in which
genes active during neurogenesis were shown to be dy-
namically marked by H3K27me3 and interference with
demethylation of H3K27me3 prevented proper acquisi-
tion of a neural fate [1, 6, 7]. Conditional knock out
(cko) of Ezh2 in the developing murine forebrain around
embryonic day (E) 10, i.e. before onset of neurogenesis,
shifted the balance between self-renewal and differenti-
ation of neural progenitors cells (NPCs) towards
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neuronal differentiation [8]. Similarly, the PRC1 compo-
nent, Bmi1, was shown to control proliferation and self-
renewal of NPCs during embryonic development by
repressing the cell cycle inhibitor p21 [9]. However, at a
later stage of cortical development, PcG proteins were
reported to regulate the timely transition from neuro-
genesis to astrogenesis by repressing, among others, the
proneural transcription factor Neurog1 [10]. These data
reveal additional roles of Ezh2 during central nervous
system development, apart from regulating stem cell
properties. In support of this notion, downregulation of
Ezh2 in NPC cultures derived from the forebrain at E14
promoted astrogenesis at the expense of oligodendrocyte
development [11]. In contrast, conditional deletion of
Ezh2 in the neural crest did not affect stem cell prolifer-
ation and self-renewal nor timely neurogenesis and glio-
genesis in the peripheral nervous system [12]. Together,
these findings demonstrate that PcG proteins function in
a cell type- and stage-dependent manner during neural
development, presumably by repression of distinct sets
of target genes.
To further address this issue, we conditionally deleted
Ezh2 in the developing murine midbrain. Loss of Ezh2
resulted in drastically reduced growth of midbrain
NPCs, which we found to involve derepression of spe-
cific cell cycle inhibitors as well as reduced canonical
Wnt signaling. Moreover, Ezh2 ablation in the midbrain
led to derepression of a forebrain transcriptional pro-
gram associated with reduced expression of midbrain
markers. Thus, our study not only provides mechanistic
insights on how NPC pool size is regulated in the mid-
brain, but also reveals a novel function of Ezh2 in con-
solidating regional identities in the developing brain.
Results
Conditional inactivation of Ezh2 in the developing
midbrain affects progenitor cell expansion
To address the role of Ezh2-mediated H3K27me3 in the
developing midbrain, we conditionally deleted Ezh2 in
mice homozygous for the floxed allele of Ezh2 using the
Wnt1-Cre allele (Fig. 1a) [10, 12]. Wnt1-Cre+/Ezh2[SE-
T]lox/lox conditional knock-out (Ezh2 cko) mice survive
to late developmental stages, but die around E18, dis-
playing craniofacial abnormalities and heart malforma-
tions caused by concomitant activity of Wnt1-Cre in the
neural crest [12]. In the midbrain, ablation of Ezh2 was
evident from E10.5 onwards (Additional file 1: Figure S1).
Of note, Ezh1 expression was very low in the embryonic
midbrain and, importantly, was not affected upon condi-
tional Ezh2 inactivation (Additional file 1: Figure S1).
Ezh2 loss was associated with widespread loss of
H3K27me3, as shown by immunohistochemistry at
E12.5 (Fig. 1b, c). Using the ROSA26 Cre reporter allele
driving β-galactosidase expression, we could also show full
Wnt1-Cre-mediated recombination in the caudal mid-
brain [13]. Histological analyses revealed a marked reduc-
tion of the neuroepithelial thickness in the midbrain of
Ezh2 cko embryos at E12.5 as compared to normal em-
bryos, which was even more pronounced at E14.5 (Fig. 1d).
Furthermore, horizontal expansion of the neuroepithelium
was decreased in mutant midbrains, as was most apparent
in the isthmal and inferior tectal region at E12.5 (Fig. 1d).
These data are consistent with altered cell cycling of
mutant neuroepithelial progenitor cells [14]. Indeed, the
number of proliferative cells incorporating the thymidine
analogue EdU during a 1-hour EdU pulse was signifi-
cantly reduced in the developing midbrain of Ezh2 cko
embryos at E12.5 as compared to control littermates
(Fig. 2a). The decrease of proliferative cells in the mu-
tant midbrain could be associated with mutant neuroepi-
thelial cells preferentially choosing to exit rather than to
remain in the cell cycle. To address this possibility, we
determined the fraction of Ki67-positive dividing cells
after a BrdU pulse of 24 hours. Cells that had left the
cell cycle were BrdU-positive but Ki67-negative, while
cells that were still in the cell cycle at the time point of
analysis were both BrdU- and Ki67-positive. At E12.5, a
highly significant increase of cells exiting the cell cycle
was detectable in the mutant as compared to the control
(Fig. 2b). Immunohistochemistry for the NPC marker
Sox2 and the differentiation marker Dcx further demon-
strated that decreased proliferation in the midbrain of
Ezh2 cko embryos at E12.5 was accompanied by a reduc-
tion in the number of progenitor cells and a concomi-
tant increase in differentiation (Fig. 2c). The increased
neurogenesis in the Ezh2 cko midbrain was also con-
firmed at E14.5 (Additional file 1: Figure S2). Cell sur-
vival was impaired in the dorsal rostral midbrain of
mutant embryos but unchanged in the area used for
quantification of mitotic cells (Fig. 2d). Thus, Ezh2 is es-
sential for proper midbrain formation by controlling the
pool size of NPCs.
Ezh2 controls proliferation of neural progenitor cells by
repressing cell cycle regulators and inhibitors of Wnt
signaling
To identify the molecular mechanisms mediating Ezh2-
dependent midbrain development, we used microarray
analysis to compare the global gene expression patterns of
control versus Ezh2 cko cells isolated from the dorsal mid-
brain of E10.5 embryos. Cluster analysis of the transcrip-
tome data indicated that the vast majority of differentially
expressed genes were transcriptionally upregulated upon
loss of Ezh2 (Fig. 3a). This is consistent with the role of
Ezh2 as a transcriptional repressor [15]. Gene ontology
analysis of process networks revealed that differentially
expressed genes were involved, among others, in negative
regulation of proliferation, Wnt signaling, and cell cycle
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regulation (Additional file 1: Figure S3). Since misregula-
tion of those processes very likely contributes to the de-
scribed mutant phenotype, we focused our analysis on the
aforementioned process networks. Among the genes dere-
pressed in Ezh2 cko cells, were the cyclin-dependent kin-
ase inhibitors (Cdkn) 2a and 2c, which negatively regulate
cellular proliferation [16–19]. Increased expression of
Cdkn2a and Cdkn2c was also demonstrated by quantita-
tive RT-PCR performed on midbrain cells isolated from
E11.5 embryos (Fig. 3b). Moreover, in situ hybridization
on sagittal sections of E12.5 control and mutant midbrains
revealed the specific increase in expression of the cell
cycle inhibitor Cdkn2a in Ezh2 cko embryos (Fig. 3d). Fi-
nally, we performed an H3K27me3 ChIP assay on wild-
type E11.5 midbrain cells and revealed that the promoters
of Cdkn2a and Cdkn2c were occupied by H3K27me3.
Thus, these cell cycle inhibitors appear to be direct targets
of Ezh2-mediated epigenetic repression (Fig. 3c).
In addition, we also found other potentially relevant
genes to be differentially expressed upon loss of Ezh2. In
particular, inhibitors of the Wnt signaling pathway, such
as Wif1 and Dkk2 [20, 21], were also significantly upreg-
ulated in Ezh2 cko cells (Fig. 3a,b,e). H3K27me3 ChIP
analysis confirmed that these Wnt signaling inhibitors
appear also to be direct targets of Ezh2 activity (Fig. 3c).
Canonical Wnt signaling has been demonstrated to control
maintenance of midbrain neuroepithelial cells [22, 23].
Therefore, we investigated whether Wnt signal activity is
indeed affected by loss of Ezh2. To this end, we made use
of the BAT-gal Wnt signaling reporter allele, which
Fig. 1 Wnt1-Cre-mediated Ezh2/H3K27me3 ablation affects midbrain
expansion. (a) Left panel: scheme of the recombination area of the
Wnt1-Cre line (indicated in blue) in the murine midbrain at E12.5. Wnt1-
Cre+/Ezh2[SET]lox/wt and Wnt1-Cre−/Ezh2[SET]lox/lox mice are used as control
while Wnt1-Cre+/Ezh2[SET]lox/lox animals are referred to as Ezh2 conditional
knock-out (cko). Right panel: Wnt1-Cre-driven recombination of the R26R
reporter allele has been visualized by immunostaining against β-
galactosidase, confirming recombination of the midbrain. Note that
neural crest cells giving rise to craniofacial structures (white arrow) are
also Wnt1-Cre recombined. (b) Immunostaining for Ezh2 reveals
complete and partial ablation of Ezh2 protein in the caudal and rostral
dorsal midbrain, respectively. (c) β-galactosidase immunostaining con-
firms full recombination of the caudal midbrain resulting in the absence
of Ezh2 protein (upper panel) and the H3K27me3 repressive mark in the
mutant (lower panel). (d) Hematoxylin and eosin staining (H&E) on sagit-
tal midbrain sections at E12.5 (upper panel) and E14.5 (lower panel).
Ezh2-deficient midbrains show reduced horizontal expansion in the infer-
ior tectal region from E12.5 onwards (white arrowheads). n ≥3 in each
group, ***P ≤0.001, Student’s t-test. Also, mutant neuroepithelium at
E14.5 is thinner than the control highlighted by the grey brackets in high
magnification pictures (asterisk indicates basal). Note that at
E14.5 recombined neural crest-derived mesenchyme between neural
epithelium and surface ectoderm is expanded in the mutant. DAPI
staining serves as nuclear marker: a (right panel), b, c (lower panel);
Scale bars: a, b, 500 μm; c, 40 μm; d, 200 μm; Error bars indicate SD; FB,
Forebrain; MB, Midbrain; ctrl, Control
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monitors β-catenin activity by driving β-galactosidase ex-
pression in Wnt signaling-active cells [24]. In mice harbor-
ing this reporter allele, we observed a prominent reduction
in the number of β-galactosidase-positive neural cells in the
Ezh2 cko midbrain at E12.5, as compared to the control
(Fig. 3f). Accordingly, targets of Wnt signaling, such as
CyclinD1 and Lef1, were downregulated in the mutant
midbrain, as shown by immunohistochemistry and quanti-
tative RT-PCR, respectively (Fig. 3g,h).
Our data indicate that reduced canonical Wnt signal-
ing might also contribute to the phenotype of Ezh2 cko
mice. To better understand the role of canonical Wnt
signaling in regulating midbrain size, we took advantage
of a mutant allele of the Wnt signaling component β-
catenin (Ctnnb1dm/flox referred to as Ctnnb1 sign mt)
that disrupts Wnt/β-catenin-mediated transcriptional
output but not cell-cell adhesion [22, 25]. While total
loss of β-catenin leads to disintegration of the midbrain
[22], loss of β-catenin signaling function did not affect
the integrity of the neuroepithelium. However, very simi-
lar to Ezh2 cko embryos (Fig. 1), the thickness and over-
all size of the midbrain was drastically reduced in Wnt1-
Cre/Ctnnb1 sign mt cko mice at E12.5 (Fig. 3i). There-
fore, Ezh2 appears to regulate the size of the developing
midbrain both by direct repression of cell cycle inhibi-
tors and, indirectly, by sustaining β-catenin signaling.
Ezh2 represses forebrain identity in the developing
midbrain
Intriguingly, the microarray analysis of control and Ezh2
cko midbrain pointed to an additional set of Ezh2-regulated
genes that are known to exhibit brain area-specific, rather
than general cellular functions in the developing neuro-
epithelium. Notably, several forebrain specification genes
were derepressed in Ezh2 cko midbrains (Fig. 3a). In situ
hybridization experiments, immunohistochemistry, and
quantitative RT-PCR experiments were used to corroborate
this finding. While normally Foxg1 is strongly expressed in
the forebrain but absent in the midbrain, it was upregulated
in the midbrain of Ezh2 cko embryos at E12.5 (Fig. 4a). A
quantitative analysis at E11.5 revealed a more than 75-fold
induction of Foxg1 expression in the mutant midbrain
(Fig. 4e). Likewise, the midbrain is normally devoid of Pax6
expression, whereas upon loss of Ezh2, Pax6 became
broadly expressed in the midbrain, displaying a 22-fold in-
duction at E11.5 (Fig. 4b,e). Furthermore, the forebrain
markers Dlx2 and Emx1 were ectopically expressed in the
midbrain of Ezh2 cko embryos at E11.5 (Fig. 4d,e). How-
ever, when comparing mRNA levels of Ezh2, Pax6, Foxg1
and Emx1 in wildtype forebrain, wildtype midbrain, and
Ezh2 cko midbrain of E12.5 embryos it became apparent
that expression levels of ectopic forebrain markers in the
mutant midbrain did not reach those of the forebrain
(Fig. 4a; Additional file 1: Figure S4).
In most rostral regions of the dorsal midbrain, Ezh2-
dependent H3K27me3 was only partially depleted in
Ezh2 cko embryos (Additional file 1: Figure S5). Incom-
plete Wnt1-Cre-mediated recombination was shown by
tracking of recombined cells using the aforementioned
ROSA26 Cre reporter allele (R26R) [13]. Therefore, non-
recombined cells were intermingled with clusters of
Fig. 2 Ezh2-deficient neural progenitor cells (NPCs) show reduced
proliferation and precocious cell cycle exit. (a–c) Confocal images of
the inferior tectal midbrain at E12.5 with respective quantification.
Cartoon insert indicates area of analysis for a–c. (a) Immunostaining
against the thymidine analogue EdU after 1-h pulse labeling reveals
reduced proliferation of NPCs in Ezh2-deficient cells. n ≥3 in each
group, ***P ≤0.001, Student’s t-test. (b) After a 24-h BrdU pulse, staining
against BrdU and the proliferation marker Ki67 distinguishes cells
that have exited the cell cycle as BrdU-positive and Ki67-negative.
Quantification of BrdU+Ki67−/BrdU+ cells demonstrates increased cell
cycle exit of mutant NPCs. n ≥3 in each group, ***P ≤0.001, Student’s
t-test. (c) Ezh2-deficient NPCs differentiate precociously as the quantifica-
tion of Sox2-positive NPCs and Dcx-positive neurons show. n ≥3 in each
group, *P ≤0.05, Student’s t-test. (d) Immunostaining for cleaved Cas-
pase3 on sagittal midbrain sections reveals increased apoptosis in the
dorsal midbrain of the mutant as compared to the control. In
contrast, higher magnification confocal micrographs of the inferior
tectal midbrain (indicated by the white asterisk) display no apoptosis.
DAPI staining serves as nuclear marker for all images. Scale bars: a–c,
40 μm, d, 200 μm (left panel), 40 μm (right panel); Error bars indicate
SD; ctrl, Control
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Fig. 3 Neural progenitor cell proliferation is controlled by Ezh2-mediated repression of cell cycle and Wnt/β-catenin signaling inhibitors. (a) Microarray
analysis of three dissected E10.5 control and mutant midbrains identified 126 differentially expressed genes (≥1.75×, P ≤0.01), the majority of which
(114) are upregulated upon Ezh2 ablation. Genes further analyzed are indicated. (b) qRT-PCR for Ezh2, cell cycle regulators Cdkn2a and Cdkn2c, and
Wnt signaling inhibitors Wif1 and Dkk2 on control and mutant E11.5 midbrains confirms microarray data. n ≥3 in each group, ***P ≤0.001, **P ≤0.01,
*P ≤0.05, Student’s t-test. (c) Chromatin immunoprecipitation confirms the presence of H3K27me3 at the transcription start site (±500 bp) of Cdkn2a,
Cdkn2c, Wif1, and Dkk2. Intergenic region Int1 serves as unmethylated negative control. n ≥3 in each group, ***P ≤0.001, **P ≤0.01, Student’s t-test.
(d–e) In situ hybridization for Cdkn2a (d) and Wif1 (e) mRNA illustrates increased gene expression in Ezh2 mutants. (f) Immunostaining for β-
galactosidase + cells on the BAT-gal Wnt/β-catenin signaling reporter line demonstrates diminished signaling in Ezh2-deficient midbrains. n ≥3 in each
group, **P ≤0.01, Student’s t-test. Cartoon insert indicates area of analysis for f and g. (g) Immunostaining against CyclinD1 and qRT-PCR. (h) Ccnd1 and
Lef1 Wnt signaling downstream targets show decreased expression upon Ezh2 ablation. n ≥3 in each group, ***P ≤0.001, **P ≤0.01, Student’s t-test.
(i) H&E staining of E12.5 sagittal midbrain sections of controls and Wnt/β-catenin signaling-ablated embryos. Mutant embryos exhibit reduced
neuroepithelium thickness indicated with grey brackets in the magnifications. DAPI staining serves as nuclear marker: f, g; Scale bars: d, e, 100 μm;
f, g, 40 μm; i, 400 μm; Error bars indicate SD; ctrl, Control; dMB, Dorsal midbrain; vMB, Ventral midbrain
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Fig. 4 Establishment of forebrain identity in Ezh2-ablated midbrain cells. (a) Upper panel: antibody staining for forebrain-specific transcription factor
Foxg1 on sagittal brain sections at E12.5 demonstrates forebrain-restricted Foxg1 expression in the control and ectopic Foxg1 expression in the dorsal
mutant midbrain. The cartoon indicates regular Foxg1 expression. Lower panel: high-magnification confocal images of immunostaining for Ezh2 and Foxg1
show ectopic Foxg1 expression in Ezh2-ablated cells (asterisk indicates basal). (b) Upper panel: antibody staining for Pax6 reveals ectopic Pax6 expression in
the Ezh2 mutant midbrain. The cartoon inset illustrates regular Pax6 distribution at E12.5 rostral of the di-mesencephalic boundary indicated by a white
dotted line. Lower panel: immunostaining for Ezh2 and Pax6 reveals ectopic mosaic-like upregulation of Pax6 in Cre-recombined cells without Ezh2 (asterisk
indicates basal). (c) ChIP confirms the presence of H3K27me3 repressive mark at the transcription start site of Pax6 and Foxg1 (±500 bp). The intergenic
region Int1 is unmethylated and serves as negative control. n ≥3 in each group, ***P ≤0.001, Student’s t-test. (d–e) In situ hybridization for Dlx2 mRNA and
qRT-PCR for Foxg1, Pax6, Dlx2, and Emx1 demonstrate elevated expression of the forebrain transcription factors in Ezh2-deficient midbrains. n ≥3 in each
group, ***P ≤0.001, **P ≤0.01, *P ≤0.05, Student’s t-test. Ectopic Dlx2 expression is indicated by a black arrow (d). Downstream targets of Pax6 – Dmrta1
and Neurog2 – are induced in mutant midbrains as shown by in situ hybridization for Neurog2 mRNA (f) and qRT-PCR for Dmrta1 and Neurog2 (g).
n ≥3 in each group, ***P ≤0.001, **P ≤0.01, Student’s t-test. DAPI staining serves as nuclear marker: a, b; Scale bars: a, b, 500 μm (upper panel);
a, b, 40 μm (lower panel); d, f, 100 μm; Error bars indicate SD; ctrl, Control; FB, Forebrain; MB, Midbrain; dMB, Dorsal midbrain; vMB, Ventral midbrain
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Ezh2-deficient cells in the rostral midbrain of Ezh2 cko
embryos at E12.5 (Additional file 1: Figure S5). Strik-
ingly, in this area, Ezh2 exhibited a perfectly inverse re-
lationship with Foxg1 and Pax6 expression patterns,
respectively, pointing to cell-autonomous mechanisms
underlying the gain of forebrain markers in Ezh2 cko
midbrain cells (Fig. 4a,b). In support of this, H3K27me3
ChIP experiments performed with midbrain cells from
control embryos at E11.5 demonstrated that the fore-
brain specification genes Foxg1 and Pax6 appear to be
direct targets of Ezh2-mediated repression (Fig. 4c).
In the developing forebrain, Pax6 acts upstream of the
transcription factor Dmrta1, which itself regulates the
expression of the proneural gene Neurog2 [26]. Strik-
ingly, Pax6 upregulation in the Ezh2 cko midbrain was
associated with significant upregulation of both Dmrta1
and Neurog2 (Fig. 4f,g). Thus, although forebrain neur-
onal layer-specific markers could not be analyzed at later
stages due to the substantial mass reduction and dis-
turbed morphology of the mutant midbrain (Fig. 1d; data
not shown), our data reveal the ectopic upregulation of a
forebrain transcriptional program in the midbrain of
Ezh2 cko embryos.
Ezh2 regulates midbrain identity by indirect mechanisms
Comparable to Pax6, Foxg1, Dlx2, and Emx1 in the de-
veloping forebrain, the transcription factors Pax3 and
Pax7 have been shown to establish midbrain identity
during vertebrate brain development [27, 28]. To ad-
dress whether expression of these midbrain specification
factors was also affected by loss of Ezh2, we performed
quantitative RT-PCR and immunohistochemistry. While
expression of Pax3 and Pax7 was unchanged at E11.5 as
shown by qPCR, it was significantly downregulated at
E12.5 (Fig. 5a). Consistent with these results, immuno-
histochemistry confirmed the presence of Pax3 at E11.5
(Additional file 1: Figure S6C) and the highly reduced ex-
pression of both transcription factors at E12.5 in Ezh2 cko.
Indeed, whereas Pax3 and Pax7 were detected in the entire
dorsal midbrain neuroepithelium in control embryos, many
cells in the mutant dorsal midbrain were devoid of Pax3
and Pax7 or showed reduced staining intensity (Fig. 5b,c).
Thus, Ezh2-mediated H3K27me3 is required for proper ex-
pression of midbrain specification genes.
Our study identified the forebrain specification genes
Foxg1 and Pax6 as targets of Ezh2 activity, which is in
agreement with their increased expression in the Ezh2 cko
midbrain (Fig. 4). In contrast, the loss of midbrain identity
markers in Ezh2 cko embryos cannot be explained by dir-
ect Ezh2-mediated repression. In chicken embryos, over-
expression of Pax6 has been reported to indirectly repress
Pax3 and Pax7 expression in the trigeminal placode and at
the forebrain-midbrain boundary, respectively [29, 30].
However, while we found Pax6 to be strongly upregulated
in the Ezh2 cko midbrain already at E11.5 (Fig. 4e), Pax3
and Pax7 were downregulated at E12.5 only (Fig. 5a), rather
arguing against control of the midbrain specification factors
by Pax6. To directly address this hypothesis, we performed
in utero electroporation of a Pax6-overexpression vector to-
gether with a GFP expression vector. In parallel we electro-
porated the GFP expressing vector alone as a control.
Monitoring GFP expression two days after in utero electro-
poration revealed the efficient targeting of the murine dorsal
midbrain by this method (Additional file 1: Figure S7A).
Coronal sections of electroporated midbrains were then
used to quantify the number of Pax3- and Pax7-expressing
cells per GFP-positive cells by immunofluorescence. For
each condition, the midbrains of three embryos were elec-
troporated and more than 800 cells were analyzed (Add-
itional file 1: Figure S7B). However, as shown in Fig. 6a and
Additional file 1: Figure S7C, ectopic expression of Pax6
did not influence Pax3 and Pax7 expression in dorsal mid-
brain cells. Hence, increased Pax6 expression is apparently
unable to repress Pax3 and Pax7 in the established murine
midbrain and is, therefore, unlikely the cause for downregu-
lated expression of midbrain fate determinants in Ezh2 cko
embryos.
Previously, Wnt/β-catenin signaling was shown to acti-
vate Pax3 and Pax7 expression in the lateral neural plate
and during neural tube closure [31–33]. Therefore, re-
duced Pax3/Pax7 expression in the Ezh2 cko midbrain
might be due to decreased canonical Wnt signaling in
mutant brain tissue (Fig. 3). To investigate whether
Wnt/β-catenin is required for expression of Pax3 and
Pax7 in the dorsal midbrain, we performed immunohis-
tochemistry on sagittal sections of Wnt1-Cre/Ctnnb1
sign mt cko embryos at E12.5. Loss of β-catenin signal-
ing not only affected midbrain size, but also resulted in
drastically reduced expression of both Pax3 and Pax7
(Fig. 6b,c). In fact, the midbrains of Wnt1-Cre/Ctnnb1
sign mt cko embryos displayed a phenotype very com-
parable to the one of Ezh2 cko embryos (Fig. 5), with
many mutant cells lacking Pax3 and Pax7 expression.
Thus, the loss of midbrain identity markers in the
Ezh2 cko midbrain is apparently caused by indirect
mechanisms, involving Ezh2-mediated control of ca-
nonical Wnt signaling.
Discussion
Epigenetic information can be passed from a dividing cell
to its daughter cells, which is thought to support inhe-
ritance of specific gene expression patterns. In this way,
epigenetic mechanisms supposedly consolidate cellular
identities as, for instance, upon differentiation of a multi-
potent cell into a specific cell type [1]. In our study, we
show that this mechanism is also involved in sustaining
regional identity in the developing brain: Ezh2-mediated
gene repression prevents midbrain cells from acquiring
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forebrain traits. Accordingly, conditional loss of Ezh2 in
midbrain NPCs not only affected their proliferation, but
also resulted in derepression of a forebrain transcriptional
program. We demonstrate that both the control of cell
cycle progression and maintenance of regional identity in-
volve direct H3K27me3-dependent gene repression as well
as indirect mechanisms mediated, in particular, by modu-
lation of canonical Wnt signaling (Fig. 7).
In many systems, Ezh2-dependent transcriptional con-
trol often guards the stem/progenitor state by repressing
cell cycle exit and differentiation. This has also been
shown for the developing forebrain, where Ezh2 regu-
lates the transition from NPC proliferation to differenti-
ation at a stage before overt neurogenesis [8]. In this
previous study, loss of Ezh2 was associated with upregu-
lation of several genes specifically expressed in differen-
tiating cortical neurons. In contrast, expression of
negative cell cycle regulators was normal or only slightly
altered in the Ezh2 cko forebrain [8]. Our work reveals
that, similar to its role in the forebrain, Ezh2 is required
for proper growth of the midbrain. Conditional Ezh2 de-
letion resulted in drastically reduced numbers of prolif-
erative midbrain NPCs, associated with elevated cell
cycle exit and differentiation. Consistent with this
phenotype, but different from the Ezh2 cko forebrain
[8], the cyclin-dependent kinase inhibitors Cdkn2a (also
known as p16) and Cdkn2c (also known as p18) were
directly regulated by Ezh2-mediated H3K27me3 in mid-
brain cells (Fig. 7). In addition, Wnt signaling inhibitors
turned out to also be Ezh2 targets in the developing
midbrain. Consequently, Wnt/β-catenin signal activity
was significantly reduced upon loss of Ezh2. In the mid-
brain, Wnt1 is thought to maintain cells in a prolifera-
tive state [34, 35]. Accordingly, Wnt1 overexpression led
to massive expansion of midbrain tissue [36]. In agree-
ment with this earlier work, inactivation of the transcrip-
tional output of Wnt signaling by means of a mutant β-
catenin allele [22] impeded midbrain growth. Although
the phenotype was more drastic when Wnt/β-catenin
signaling was completely inactivated as opposed to only
reduced in Ezh2 cko embryos, our findings demonstrate
how the regulation of a crucial signaling pathway by
Fig. 5 Ezh2 regulates midbrain identity indirectly. (a) qRT-PCR for Ezh2,
Pax3, and Pax7 on midbrain tissue isolated at E11.5 and E12.5 reveals a
downregulation of midbrain transcription factors Pax3 and Pax7 in the
absence of Ezh2 after E11.5. n ≥3 in each group, ***P ≤0.001, Student’s
t-test. (b, c) Immunostaining for Pax3 (b) and Pax7 (c) on sagittal
midbrain sections shows diminished protein levels at E12.5 (magnification
in lower panels, asterisk defines basal). The cartoon insets indicate
regular Pax3 and Pax7 expression at E12.5, respectively. DAPI
staining serves as nuclear marker: b, c; Scale bars: b, c, 500 μm
(upper panel); b, c, 40 μm (lower panel); Error bars indicate SD;
MB, Midbrain
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epigenetic repression contributes to the proper control
of brain size (Fig. 7).
Surprisingly, apart from negative cell cycle regulators
and Wnt signaling inhibitors, the forebrain determinants
Pax6 and Foxg1 were also among the genes upregulated
in the Ezh2-deficient midbrain neuroepithelium.
Fig. 7 Proposed model for the role of Ezh2 in mouse midbrain
development. Ezh2 controls neural progenitor proliferation and brain
area identity via direct and indirect mechanisms. Ezh2 regulates cell
cycle progression by H3K27me3-mediated repression of negative cell
cycle regulators Cdkna2 and Cdkn2c and Wnt/β-catenin signaling
inhibitors Wif1 and Dkk2. Also, Ezh2 maintains midbrain identity of
cells by suppressing forebrain determinants Foxg1 and Pax6 and by
maintaining Wnt/β-catenin signaling, which is essential for the
expression of midbrain markers Pax3 and Pax7. Therefore, loss of
Ezh2 in the developing mouse midbrain leads to decreased proliferation
and precocious cell cycle exit of neural progenitors in addition
to a partial loss of midbrain identity and ectopic establishment
of forebrain identity
Fig. 6 Midbrain markers are not directly repressed by Pax6 but are
regulated indirectly by Wnt/β-catenin signaling. (a) A Pax6 overexpression
construct together with a GFP-expressing vector (Pax6OE) or a GFP-ex-
pressing vector alone (Control) were delivered by in utero
electroporation into the dorsal midbrain at E13.5. Two days later the
proportion of GFP+ cells expressing midbrain markers Pax3 and Pax7 was
analyzed. Overexpression of Pax6 does not affect the proportion of
midbrain marker-expressing cells. n = 3 in each group, two different litters
(also see Additional file 1: Figure S7B). (b, c) Immunostaining for Pax3 (b)
and Pax7 (c) at E12.5 reveals decreased protein levels in midbrains with
ablated Wnt/β-catenin signaling (Ctnnb1 sign mt) compared to control.
Cartoon insets show regular expression pattern, asterisk indicates basal.
DAPI staining serves as nuclear marker: b, c; Scale bars: b, c, 500 μm
(upper panel); b, c, 40 μm (lower panel); Error bars indicate SD; IUE, in
utero electroporation; ctrl, control; Ctnnb1 sign mt, Wnt/β-catenin signal-
ing mutant; MB, midbrain
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Moreover, the promoters of both of these genes were
marked by H3K27me3 in the midbrain. In embryonic
stem cells, the Pax6 promoter is enriched for
H3K27me3, which is removed when the cells acquire a
forebrain neural fate [37]. Furthermore, Pax6 is one of
the Ezh2-repressed genes in the murine heart [19]. How-
ever, Pax6 has not been identified before as an Ezh2 tar-
get in the context of the murine brain in vivo. We now
show that Pax6 is derepressed in Ezh2-deficient mid-
brain cells from E10.5 to E12.5. During this timeframe,
midbrain NPCs progress through the cell cycle at least
twice [14], indicating that gene derepression mediated
by Ezh2 loss is maintained through cell division. More
importantly, we found Pax6 derepression in the Ezh2-de-
ficient midbrain to be accompanied by activation of a
forebrain transcriptional program that included Pax6,
Foxg1, Dlx2, Emx1, and the transcription factors Dmrta1
and Neurog2, which themselves are downstream targets
of Pax6 [26, 38]. Thus, Ezh2 represses a forebrain fate in
the midbrain (Fig. 7). Presumably, additional factors
would be required in an epigenetically derepressed mid-
brain to implement later forebrain features, such as
characteristic layer formation and differentiation into
specific neuronal subtypes. However, this cannot be
achieved the Ezh2 cko midbrain, because of the afore-
mentioned other major role of Ezh2 in regulating mid-
brain growth.
Along with the gain of forebrain identity in Ezh2-
deficient midbrain tissue, we observed a substantial reduc-
tion in the expression of dorsal midbrain markers Pax3 and
Pax7, which are key regulators of midbrain development
[27]. Unlike the changes in forebrain markers, reduced
Pax3 and Pax7 expression was delayed upon loss of Ezh2
protein. Likewise, early expression of the midbrain pattern-
ing markers, Otx2, Fgf8, Pax2, and En2 [34, 39–41], was
not affected in the midbrain lacking Ezh2 (Additional file 1:
Figure S6A, B, D, E). Together with the initially normal
expression of Pax3 and Pax7 in the Ezh2 cko midbrain,
our findings indicate that Ezh2 is not involved in the
early establishment of midbrain identity, but rather in
its maintenance.
The delayed timing of midbrain marker loss and the
canonical function of Ezh2 as a transcriptional repressor
suggested that Pax3 and Pax7 expression is indirectly
controlled by Ezh2. Apparently, this did not involve
Pax6-dependent downregulation of Pax3/7 as demon-
strated by in utero electroporation of Pax6 in the speci-
fied dorsal midbrain. In chicken, Pax6 overexpression
has been shown before to repress Pax3 and Pax7 expres-
sion in neural tissue [29, 30]. Since in these studies,
Pax6-dependent regulation of Pax3/7 was indirect and
mediated by a hitherto unidentified repressor, we propose
that this repressing function might either be absent in the
mammalian midbrain or at a stage when the Pax3/Pax7
expression domains have already been established. How-
ever, our work reveals an alternative mechanism for how
midbrain-specific markers are being lost upon Ezh2 inacti-
vation – indeed, reduced canonical Wnt signaling not only
interfered with midbrain growth, but also with the continu-
ous expression of Pax3 and Pax7 (Fig. 7). This finding was
corroborated by the analysis of mutant midbrains, in which
Wnt/β-catenin signaling was conditionally depleted.
Conclusion
The change of brain area identities caused by loss of
Ezh2 involves H3K27me3-mediated derepression of
forebrain-specific transcription factors and indirect re-
duction of canonical Wnt signaling due to derepression
of Wnt signal inhibitors. Thus, our study identifies epi-
genetic repression of multiple transcription factors and a
central signaling pathway as a key mechanism in sustain-
ing brain growth and regional identity.
Methods
Animal models
All animal experiments were conducted in accordance with
Swiss guidelines and approved by the Veterinary Office of
the Canton of Zurich, Switzerland. Previously described
Ezh2[SET]lox/lox mice [10] were crossed to Wnt1-Cre mice
[42] to ablate Ezh2 function in the developing midbrain
from E9.5. Wnt1-Cre+/Ezh2[SET]lox/lox mice are re-
ferred to as Ezh2 cko while Wnt1-Cre−/Ezh2[SET]lox/lox and
Wnt1-Cre+/Ezh2[SET]wt/lox littermates were used as control
animals. All genotypes were present at Mendelian ratios
and control animals showed no overt phenotype. Add-
itionally, Ezh2 mice were crossed to a Cre-reporter line
carrying the R26RlacZ allele [13] or to the canonical Wnt/
β-catenin-signaling reporter mouse BAT-gal [24]. Also,
floxed Ctnnb1 mice were crossed to Ctnn1dm [22, 25]
under the Wnt1-Cre driver to generate mice with ablated
Wnt/β-catenin signaling in the midbrain referred to as
Ctnnb1 sign mt. All animals were bred on a C57/BL6
background. To generate embryos of a certain develop-
mental stage, mice were mated overnight and the next
morning was defined as E0.5.
Staining procedures
Embryo heads or E15.5 brains were dissected, washed in
PBS and fixed overnight in 4 % paraformaldehyde at 4 °C,
followed by dehydration in ethanol and paraffin embed-
ding. Sagittal or coronal 5-μm paraffin sections were
deparaffinized, high-pressure antigen retrieval in citrate
buffer (pH 6) was performed, and sections were subse-
quently stained following standard protocols. Primary
antibodies used were mouse anti-Ezh2 (Cell Signaling
Technology, #3147, 1:75), rabbit anti-H3K27m3 (Cell
Signaling Technology, #9733, 1:500), chicken anti-β-
galactosidase (Abcam, ab9361, 1:2000), rabbit anti-
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cleaved Caspase 3 (Cell Signaling Technology, #9661,
1:100), mouse anti-BrdU (Cell Signaling Technology, #5292
1:100), anti-Ki67 (rat Dako M7249, 1:50 and rabbit Abcam,
ab15580, 1:200), rabbit anti-Dcx (Abcam, ab18723, 1:200),
mouse anti-Sox2 (R&D, MAB2018, 1:100), mouse anti-
CyclinD1 (Santa Cruz Biotechnology, sc-450, 1:200), anti-
Pax6 (mouse DSHB, 1:50 and rabbit Covance, PRB-278P,
1:200), rabbit anti-Pax3 (Invitrogen, 38–1801, 1:100),
mouse anti-Pax7 (DSHB Iowa, 1:100), chicken anti-GFP
(Aves, GFP-1020, 1:300), rabbit anti-Pax2 (Zymed, 71–
6000, 1:100), and rabbit anti-Foxg1 (Abcam, ab18259,
1:50). Secondary antibodies used were Alexa Fluor
546 goat anti-mouse IgG1 (Invitrogen, A-21123, 1:500),
DyLight 488 goat anti-rabbit IgG (Jackson, 111-485-003,
1:500), DyLight 488 goat anti-chicken IgG (Jackson, 111-
545-155, 1:500), and Cy3 goat-anti rabbit IgG (Jackson,
111-165-003, 1:500). Nuclei were stained with DAPI
(Sigma, 1:1000).
For assessment of neural progenitor proliferation
30 mg/kg body weight thymidine analogue EdU was
injected intraperitoneally (i.p.) into pregnant females 1 h
before sacrificing the animals. Click-iT® EdU Alexa Fluor®
488 HCS Assay (life technologies, C10350) was used for
visualizing incorporated EdU on brain sections. For cell
cycle exit, 40 mg/kg body weight BrdU was injected i.p.
into pregnant females 24 h before sacrificing the animals.
For antibody staining against BrdU, high pressure antigen
retrieval was followed by treatment of sections with 1 M
HCl for 15 min at 25 °C and neutralization with 0.1 M so-
dium borate, pH 8.5, 2× 15 min. H&E was performed as
previously described [43].
In situ hybridization
Non-radioactive in situ hybridization with digoxigenin-
labeled riboprobes was performed on paraffin sections.
After deparaffinization and tissue treatment with 15–
25 μg/mL proteinase K (Roche) for 5 min at 25 °C, a
standard protocol was followed [44]. In situ probes for
Cdkn2a, Wif1, and Foxg1 were generated by in vitro
transcription of PCR amplified genomic DNA fragments
of about 500–900 bp. Primers used for PCR amplifica-
tion are listed in Table S2 (Additional file 1: Table S2).
In situ probes for Neurog2, Otx2, Fgf8, and En2 had
been previously generated in the lab. John Rubenstein,
USA, kindly provided the Dlx2 probe.
Quantitative real-time PCR and microarray analysis
After tissue isolation from dorsal midbrains, total RNA
was isolated with the RNAeasy kit (Qiagen) and RNase-
Free DNase Set (79254, Qiagen) following the manufac-
turer’s instructions. For quantitative real-time PCR,
0.5 μg RNA were reverse transcribed with the Maxima
First Strand cDNA Synthesis kit (Fermentas, K1641) and
1 μL of cDNA was used as input for quantitative real-time
PCR. The reaction was carried out using LightCycler®
SYBR Green I master mix (Roche, 4887352001) and was
run on a LightCycler® 480 System (Roche). Each experi-
ment was performed in a minimum of biological and
technical triplicates. Obtained data were analyzed by
the ΔCt method and normalized to the expression
levels of β-actin. Primers used are listed in Table S3
(Additional file 1: Table S3).
Isolated total RNA of E10.5 control (n = 3, from two dif-
ferent litters) and Ezh2 cko (n = 3, from two different lit-
ters) dorsal midbrains was used for microarray analysis
performed at the Functional Genomics Center Zurich,
Switzerland, using the Affymetrix A430 platform. The heat
map in Fig. 3a and gene list in Table S1 (Additional file 1:
Table S1) show differentially expressed genes with ≥1.75-
fold change (P ≤0.01). Gene ontology network analysis was
performed with MetaCore (Thomson Reuters). Obtained
microarray data have been deposited in NCBI’s Gene Ex-
pression Omnibus [45] and are accessible through GEO
Series accession number GSE74538.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described [46] on
chromatin prepared from dorsal midbrains of E11.5
NMRI embryos. A rabbit mab anti-H3K27me3 antibody
(Cell Signaling Technology, #9733, 1:250) was used.
Purified DNA (1 μL) was used as input for the quantita-
tive real-time PCR and the reaction was carried out
using LightCycler® SYBR Green I master mix (Roche,
4887352001), run on a LightCycler® 480 System (Roche).
Primers were designed to amplify genomic DNA from a
region flanking the transcriptional starting site ±500 bp
and is devoid of local CpG islands. Primers used are
listed in Table S4 (Additional file 1: Table S4). Obtained
data were analyzed by the ΔCt method and normalized to
ChIP input. Also, intragenic region Int1 (chr5: 79227331–
79229070) is unmethylated and served as negative control.
Plasmid preparation and in utero electroporation
In utero electroporation in mice was performed as previ-
ously described [47]. Briefly, after plasmid DNA was
injected into the third ventricle of E13.5 brains, five elec-
tric pulses with a duration of 100 ms and an amplitude of
36 V at 400 ms intervals were applied to the dorsal mid-
brain with a pair of 3 mm diameter Tweezertrodes (BTX
Harvard Apparatus, 45–0052) using the ECM Square
Wave Electroporation System (BTX Harvard Apparatus,
45–0052). A Pax6 overexpression construct (pMF359-
Pax6 plasmid, 2 μg/μL) together with a pCX-GFP plasmid
(1 μg/μL) for the Pax6OE condition or a pCX-GFP plas-
mid (1 μg/μL) alone as control condition were introduced
into wildtype (NMRI) embryos. Plasmids were amplified
and purified using the Qiagen EndoFree Plasmid Maxi Kit
following the manufacturer’s guidelines (Qiagen, 12362).
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Two days after electroporation, the embryos were recovered
from the mother and E15.5 brains were dissected and fur-
ther processed for immunohistochemistry. The pMF359-
Pax6 vector was previously generated in the lab by cloning
Pax6 with BamHI into a pMF359 vector kindly provided by
M. Fussenegger. The pCX-GFP vector was a gift from O.
Raineteau’s laboratory.
Imaging, quantification, and statistical analysis
Epifluorescence and confocal images were taken with a
Leica DMI6000 B or a CLSM Leica SP8 upright micro-
scope, respectively, processed with Adobe Photoshop,
and quantified manually using ImageJ. For all experi-
ments and quantifications n ≥3 mutants and control em-
bryos of at least two different litters were analyzed. For
the quantification of immunostainings, at least three par-
affin sections per embryo were analyzed. Representative
images are shown in the figures. Measurement of the
neuroepithelium thickness was done in ImageJ on H&E
images. Statistical analysis was performed on Microsoft
Excel using the unpaired, two-tailed Student t-test.
Additional file
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from E10.5. Figure S2. (related to Fig. 2) Ezh2 ablation results in
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analysis. Figure S4. (related to Fig. 4) Expression levels of forebrain
transcription factors in Ezh2 cko midbrain do not reach those of wildtype
forebrain. Figure S5. (related to Fig. 4) Incomplete Cre-mediated recombin-
ation in the dorsal midbrain. Figure S6. (related to Fig. 5) Ezh2 ablation
does not affect early midbrain patterning. Figure S7. (related to Fig. 6) Pax6
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